Milestone Pharmaceuticals Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MIST research report →
About the company
Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics. Their flagship product, etripamil, an innovative channel blocker, is currently in advanced clinical development.
- CEO
- Joseph G. Oliveto
- IPO
- 2019
- Employees
- 33
- HQ
- Montreal, QC, CA
Price Chart
- Market Cap
- $113.37M
- P/E
- -1.94
- P/S
- 63.55
- P/B
- 4.77
- EV/EBITDA
- -2.92
- Div Yield
- 0.00%
- Gross Margin
- 94.67%
- Op Margin
- -3669.39%
- Net Margin
- -3832.01%
- ROE
- -339.38%
- ROIC
- -37.64%
- Revenue
- $1.55M · 0.00%
- Net Income
- $-63,058,000 · -51.88%
- EPS
- $-0.75 · -11.94%
- Op Income
- $-62,485,000
- FCF YoY
- -70.85%
- 52W High
- $3.06
- 52W Low
- $1.00
- 50D MA
- $1.51
- 200D MA
- $1.84
- Beta
- 0.96
- Avg Volume
- 1.77M
Get TickerSpark's AI analysis on MIST
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 10, 26 | Giles Lisa M. | other | 77,000 |
| Jun 10, 26 | Fischer Seth H. Z. | other | 77,000 |
| Jun 10, 26 | Duty Stuart | other | 77,000 |
| Jun 10, 26 | Wills Robert James | other | 77,000 |
| Jun 10, 26 | TOMSICEK MICHAEL JOHN | other | 77,000 |
| Jun 10, 26 | Saik Andrew | other | 77,000 |
| Jun 10, 26 | PAPA JOSEPH C | other | 77,000 |
| Apr 16, 26 | Oliveto Joseph | sell | 36,500 |
| Mar 17, 26 | Sandoval David I. | other | 400,000 |
| Feb 2, 26 | Oliveto Joseph | other | 679,000 |
Our MIST coverage
Recent articles, reports, and earnings notes.
No research on MIST yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MIST report →Similar companies
Peers in the same neighborhood.